Crizotinib
ATC L01ED01 · 11 markets · 35 records
US 5 records · 5 strengths
GB 5 records · 2 strengths
AU 5 records · 3 strengths
- 250 mgcapsuleXalkoriXALKORI crizotinib 200 mg capsule blister pack
- 200 mgcapsuleXalkoriXALKORI crizotinib 200 mg capsule blister pack
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 5 records · 5 strengths
- 250 mgcapsuleXalkori
- 200 mgcapsuleXalkori
- 150 mgcapsuleXALKORI ABRIR
- 50 mgcapsuleXALKORI ABRIR
- 20 mgcapsuleXALKORI ABRIR
CN 4 records · 2 strengths
CA 2 records · 2 strengths
SG 2 records · 2 strengths
TW 2 records · 2 strengths
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 strengths
- 250 mgcapsuleXALKORI 200 mg, gélule
- 200 mgcapsuleXALKORI 200 mg, gélule
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250 mgRecorded as: 0.25 g capsule | Xalkori | Xalkori | Xalkori | Xalkori XALKORI crizotinib 200 mg capsule blister pack | Xalkori | 赛可瑞克唑替尼 | Xalkori | Xalkori 截剋瘤膠囊250毫克 | XALKORI 200 mg, gélule | ||
| 200 mgRecorded as: 0.2 g capsule | Xalkori | Xalkori | Xalkori | Xalkori XALKORI crizotinib 200 mg capsule blister pack | Xalkori | 赛可瑞克唑替尼 | Xalkori | Xalkori 截剋瘤膠囊200毫克 | XALKORI 200 mg, gélule | ||
| 150 mg capsule | Xalkori | XALKORI ABRIR | |||||||||
| 50 mg capsule | Xalkori | XALKORI ABRIR | |||||||||
| 20 mg capsule | Xalkori | XALKORI ABRIR | |||||||||
unknown | Xalkori | Xalkori | Xalkori |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.